Tenax Therapeutics, Inc.
USD10.95
-1.02 (-8.52%)
CEO
Christopher T. Giordano
IPO Date
1994-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.75
Prev. Close
$11.97
Day Low
$10.88
Day High
$11.80
52W Low
$5.34
52W High
$18.38
Market Cap
$0.19B
Volume
0.90M
| 450,000 |
| $11.95 |
| 13 May 2026 | STAAB THOMAS R II | Chief Financial Officer | Disposed | 0 | $0.00 |
| 3 Feb 2026 | MCGAULEY THOMAS | Interim CFO | M-Exempt | Acquired | 50,000 | $12.51 |
| 13 Jan 2026 | Davidson Michael H. | director | A-Award | Acquired | 30,000 | $13.30 |
| 13 Jan 2026 | Giordano Christopher Thomas | director, officer: CEO | A-Award | Acquired | 450,000 | $13.30 |
| 13 Jan 2026 | Rich Stuart | director, officer: Chief Medical Officer | A-Award | Acquired | 250,000 | $13.30 |
| 13 Jan 2026 | PROEHL GERALD T | director | A-Award | Acquired | 3,000 | $13.30 |
| 13 Jan 2026 | Almenoff June Sherie | director | A-Award | Acquired | 30,000 | $13.30 |
| 13 Jan 2026 | Doogan Declan | director | A-Award | Acquired | 30,000 | $13.30 |